Sarvari V. Yellapragada
- Hematology top 10%
- Multiple Myeloma Research and Treatments 15
- Acute Myeloid Leukemia Research 7
- Geriatrics and Gerontology top 10%
-
- Cancer Treatment and Pharmacology 4
-
- Protein Degradation and Inhibitors 6
- Histone Deacetylase Inhibitors Research 4
-
- Lymphoma Diagnosis and Treatment 5
-
- Chronic Lymphocytic Leukemia Research 4
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
- Co-authors
- Guru SonpavdeAjjai AlvaNoah M. HahnAna M. AparicioRakesh SingalCostantine AlbanyGustavo RiveroMary T. Brophy
- Journals
- Journal of Clinical Oncology (5 papers)SHILAP Revista de lepidopterología (6 papers)Blood (9 papers)
- Partner nations
- United StatesVietnamGermany
In The Last Decade
Sarvari V. Yellapragada
41 papers receiving 311 citations
Peers
Comparison fields: 5 of 70
- Hematology 87
- Geriatrics and Gerontology 28
- Oncology 116
- Physical Therapy, Sports Therapy and Rehabilitation 10
- Pulmonary and Respiratory Medicine 68
Countries citing papers authored by Sarvari V. Yellapragada
This map shows the geographic impact of Sarvari V. Yellapragada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarvari V. Yellapragada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarvari V. Yellapragada more than expected).
Fields of papers citing papers by Sarvari V. Yellapragada
This network shows the impact of papers produced by Sarvari V. Yellapragada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarvari V. Yellapragada. The network helps show where Sarvari V. Yellapragada may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sarvari V. Yellapragada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 8 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 6 | |
| 5 | 2022 | 5 | |
| 6 | 2022 | 2 | |
| 7 | 2021 | 11 | |
| 8 | 2021 | 7 | |
| 9 | 2019 | 2 | |
| 10 | 2019 | 35 | |
| 11 | 2019 | 3 | |
| 12 | 2018 | 14 | |
| 13 | 2018 | 29 | |
| 14 | 2017 | 2 | |
| 15 | 2016 | 9 | |
| 16 | 2015 | 3 | |
| 17 | 2015 | 8 | |
| 18 | 2014 | 3 | |
| 19 | 2013 | 1 | |
| 20 | 2012 | 3 |
About Sarvari V. Yellapragada
Sarvari V. Yellapragada is a scholar working on Hematology, Genetics and Oncology, having authored 45 papers that have together received 314 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (15 papers), Acute Myeloid Leukemia Research (7 papers), Protein Degradation and Inhibitors (6 papers), Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Cancer Treatment and Pharmacology (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). The work is most often cited by research in Hematology (87 citations), Geriatrics and Gerontology (28 citations) and Oncology (116 citations). Sarvari V. Yellapragada has collaborated with scholars based in United States, Vietnam and Germany. Frequent co-authors include Guru Sonpavde, Ajjai Alva, Noah M. Hahn, Ana M. Aparicio, Rakesh Singal, Costantine Albany, Gustavo Rivero, Mary T. Brophy, Nikhil C. Munshi and Bijan Najafi. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.